| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 235k | $0.31 | $72.8k | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.00 | $0 | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 28.8k | $0.00 | $0 | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 55.5k | $0.00 | $0 | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 65k | $0.00 | $0 | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 210k | $0.96 | $201.6k | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 28.8k | $1.04 | $29.9k | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 55.5k | $1.94 | $107.7k | | 10/02/2023 |
| 10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 65k | $6.46 | $419.9k | | 10/02/2023 |
| 07/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 10.3k | $0.36 | $3.7k | | 07/03/2023 |
| 02/21/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.96 | $201.6k | | 02/21/2023 |
| 01/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 6.1k | $1.02 | $6.2k | | 01/03/2023 |
| 07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 28.8k | $1.04 | $29.9k | | 07/28/2022 |
| 07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 43.1k | $0.00 | $0 | | 07/28/2022 |
| 01/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 5k | $1.63 | $8.2k | | 01/27/2022 |
| 01/27/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 8.5k | $1.78 | $15.1k | | 01/27/2022 |
| 01/20/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 55.5k | $1.94 | $107.7k | | 01/20/2022 |
| 01/03/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 29.9k | $0.00 | $0 | | 01/03/2022 |
| 06/11/2021 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 1.5k | $5.45 | $8.2k | | 06/11/2021 |
| 03/15/2021 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Employee Stock Option (Right to Buy) | 699.1k | $2.43 | $1.7M | | 03/15/2021 |
| 03/17/2020 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Employee Stock Option (Right to Buy) | 616.7k | $0.69 | $426.7k | | 03/17/2020 |
| 08/13/2019 | Lineage Cell Therapeutics, Inc. | BTX | Purchase | Common Shares | 5k | $1.02 | $5.1k | | 07/31/2019 |
| 07/31/2019 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Employee Stock Option (Right to Buy) | 125k | $1.10 | $137.5k | | 07/31/2019 |
| 05/20/2019 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Employee Stock Option (Right to Buy) | 300k | $1.13 | $339k | | 05/20/2019 |